Understanding a patients baseline metabolic health reduces the risk of unexpected side effects and provides a safer environment for initiating therapy
In the OASIS-4 trial, people with obesity taking the 25 mg oral semaglutide pill once a day, in addition to making lifestyle changes, lost about 16.6 percent of their body weight over 64 weeks, compared to 2.7 percent with placebo, says LaValle
GHK-Cu needs to reach the scalp surface applying it to hair strands does nothing for follicles
Iron deserves a specific mention because the signal is consistent across studies
Prescribing GLP-1 agonists for AUD would constitute off-label use , which requires careful consideration of the evidence base, documented informed consent, clear rationale, appropriate monitoring, and adherence to local governance frameworks